Clinical Trial Update: Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF [Phase 3]

View source ↗

Summary

Phase III trial comparing AFOLIA to Gonal-f RFF in women undergoing IVF has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• AFOLIA (follitropin alfa)
• Gonal-f RFF (folitropin alfa)

Snippet

Sponsor: Fertility Biotech AG | Conditions: Infertility | Phase 3 | Status: COMPLETED | Results posted: 2017-10-18